|
2021
|
Invention
|
Product based on iron bis-glycinate chelate and alginic acid and/or water-soluble salts thereof, ... |
|
2020
|
Invention
|
New formulations of amisulpride. The object of the present invention are new, reduced dosage, sol... |
|
|
Invention
|
Mixture of isomers of aminaphtone, analytical method for identifying them and pharmaceutical comp... |
|
|
Invention
|
Pharmaceutical composition containing pyrrolidone carboxylic acid and metallic salt for use in th... |
|
2019
|
Invention
|
Pyrrolidone carboxylic acid (pca) for ophthalmic use. The present invention relates to pyrrolidon... |
|
2018
|
Invention
|
Use of metadoxine as hepatoprotector in the treatment of hepatic toxicity induced in patients tre... |
|
|
G/S
|
Pharmaceutical preparations; ophthalmic preparations for human use. |
|
2016
|
Invention
|
Synergistic combination of pyrrolidone carboxylic acid and/or salts thereof and hyaluronic acid a... |
|
2014
|
Invention
|
Process for the synthesis of aminaphtone. The present invention concerns a new process for the sy... |
|
2011
|
Invention
|
Method of treating raynaud's disease secondary to connectivitis using aminaphtone. The subject of... |
|
2010
|
Invention
|
Metadoxine for use as inhibitor of hepatic fibrosis.
The use of metadoxine in the treatment of h... |
|
|
Invention
|
Metadoxine for use as inhibitor of hepatic fibrosis. The use of metadoxine in the treatment of he... |
|
2007
|
Invention
|
Use of aminaphtone for the preparation of a medicament for treating arteriopathies. The subject o... |
|
1998
|
Invention
|
Geranylgeranyl-derivatives, process for the preparation thereof and related pharmaceutical compos... |
|
1996
|
Invention
|
Novel geranylgeranyl-derivatives, process for the preparation thereof and related pharmaceutical ... |
|
1994
|
Invention
|
Process of conjugation of antiviral nucleosides with lactosaminated human albumin. A conjugate of... |
|
|
Invention
|
Hepatotropic conjugates of antiviral drugs, carriers thereof and pharmaceutical compositions cont... |
|
|
Invention
|
Process for the preparation of pyridoxine 5-oxo-2-pyrrolidone carboxylate. Equimolecular quantiti... |
|
|
Invention
|
Therapeutic use of pyridoxine pyrrolidone carboxylate. Administration of pyridoxine pyrrolidone c... |
|
1993
|
Invention
|
Process of conjugation of antiviral nucleosides with lactosaminated human albumin. By carrying ou... |
|
1990
|
Invention
|
Complexable heterogenous oligosaccharides and alpha-hydosanes having therapeutical activity, proc... |
|
|
Invention
|
Sulfonamido derivative inhibiting the aldose reductase enzyme system and pharmaceutical compositi... |
|
1988
|
Invention
|
Sulfonamido derivatives inhibiting the aldose reductase enzyme system and pharmaceutical composit... |
|
1986
|
Invention
|
Conjugate of 9-(2-hydroxyethoxymethyl)-guanine with lactosaminated human albumin, process for the... |
|
1985
|
Invention
|
Method for the preparation of conjugates of adenine-9-beta-arabinofuranoside 5' monophosphate wit... |
|
|
Invention
|
Method for the preparation of conjugates of adenine-9- .beta.-arabinofuranoside 5' monophosphate ... |
|
1983
|
Invention
|
2-(.omega.-alkylaminoalkyl)-and 2-(.omega.-dialkylaminoalkyl)- 3-(4-x-benzyliden)-phtalimidines. ... |
|
|
Invention
|
2-(.omega.-alkylaminoalkyl)- and 2-(.omega.-dialkylaminoalkyl-3-(4-x-benzylidene)-phthalimidines.... |
|
|
G/S
|
Pharmaceutical, veterinary and sanitary products; plasters,
materials for dressings. |
|
|
Invention
|
Pharmaceutical composition having immunomodulating activity. The administration by oral route of ... |
|
1981
|
G/S
|
Produits pharmaceutiques. |
|
1973
|
G/S
|
Cosmétiques. Produits pharmaceutiques. |
|
1971
|
G/S
|
Dentifrices. Produits pharmaceutiques. |
|
1960
|
G/S
|
Produits pharmaceutiques, produits chimico-pharmaceutiques,
produits médicinaux, produits biolog... |
|
1957
|
G/S
|
Produit médicinal. |
|
1955
|
G/S
|
Pharmaceutical product. |
|
1950
|
G/S
|
Produits chimico-pharmaceutiques. |
